Neurone Studio S.A. (WSE:NRS)
0.7350
+0.0150 (2.08%)
At close: Jun 9, 2026
Neurone Studio Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 0.02 | - | 0 | 0.14 | 0.03 |
Short-Term Investments | - | - | - | - | - | 0.18 |
Cash & Short-Term Investments | - | 0.02 | - | 0 | 0.14 | 0.21 |
Cash Growth | - | - | - | -99.06% | -35.34% | -56.96% |
Accounts Receivable | 0.07 | - | 0 | 0 | 0.04 | 0.04 |
Other Receivables | - | 0.07 | 0.05 | 0.04 | 0.03 | 0.13 |
Receivables | 0.07 | 0.07 | 0.06 | 0.04 | 0.07 | 0.18 |
Inventory | - | - | 0.07 | 0.11 | 0.12 | 0.08 |
Total Current Assets | 0.07 | 0.08 | 0.13 | 0.15 | 0.32 | 0.47 |
Property, Plant & Equipment | - | - | - | - | - | 0 |
Other Intangible Assets | 0 | 0.01 | 0.03 | - | - | - |
Total Assets | 0.07 | 0.09 | 0.16 | 0.15 | 0.32 | 0.47 |
Accounts Payable | - | 0.01 | 0.06 | 0.03 | 0.01 | 0.01 |
Accrued Expenses | 0.01 | - | 0 | 0 | 0.01 | 0 |
Short-Term Debt | - | - | 0.42 | 0.28 | - | - |
Current Income Taxes Payable | - | 0.01 | 0.01 | 0.03 | 0.03 | 0.01 |
Other Current Liabilities | 0.18 | - | 0 | 0 | 0.16 | - |
Total Current Liabilities | 0.18 | 0.02 | 0.49 | 0.35 | 0.21 | 0.02 |
Other Long-Term Liabilities | - | 0.18 | 0.12 | 0.07 | - | - |
Total Liabilities | 0.18 | 0.19 | 0.61 | 0.42 | 0.21 | 0.02 |
Common Stock | 0.28 | 0.28 | 0.22 | 0.22 | 0.21 | 0.21 |
Additional Paid-In Capital | 4.56 | 4.56 | 4.05 | 4.05 | 3.89 | 3.89 |
Retained Earnings | -4.95 | -4.93 | -4.72 | -4.53 | -3.99 | -3.65 |
Shareholders' Equity | -0.11 | -0.1 | -0.45 | -0.27 | 0.11 | 0.45 |
Total Liabilities & Equity | 0.07 | 0.09 | 0.16 | 0.15 | 0.32 | 0.47 |
Total Debt | - | - | 0.42 | 0.28 | - | - |
Net Cash (Debt) | - | 0.02 | -0.42 | -0.28 | 0.14 | 0.21 |
Net Cash Growth | - | - | - | - | -35.34% | -56.96% |
Net Cash Per Share | - | 0.01 | -0.19 | -0.13 | 0.06 | 0.10 |
Filing Date Shares Outstanding | - | 2.77 | 2.2 | 2.2 | 2.12 | 2.12 |
Total Common Shares Outstanding | - | 2.77 | 2.2 | 2.2 | 2.12 | 2.12 |
Working Capital | -0.12 | 0.06 | -0.37 | -0.2 | 0.11 | 0.45 |
Book Value Per Share | - | -0.04 | -0.21 | -0.12 | 0.05 | 0.21 |
Tangible Book Value | -0.12 | -0.11 | -0.48 | -0.27 | 0.11 | 0.45 |
Tangible Book Value Per Share | - | -0.04 | -0.22 | -0.12 | 0.05 | 0.21 |